Latest General Catalyst Group Management, LLC Stock Portfolio
$183Million– No. of Holdings #12
General Catalyst Group Management, LLC Performance:
2026 Q1: -19.28%YTD: -19.28%2025: -31.21%
Performance for 2026 Q1 is -19.28%, and YTD is -19.28%, and 2025 is -31.21%.
About General Catalyst Group Management, LLC and 13F Hedge Fund Stock Holdings
General Catalyst Group Management, LLC is a hedge fund based in Cambridge, MA. On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, General Catalyst Group Management, LLC reported an equity portfolio of $183.6 Millions as of 31 Mar, 2026.
The top stock holdings of General Catalyst Group Management, LLC are IOT, , . The fund has invested 34.5% of it's portfolio in SAMSARA INC and 18.8% of portfolio in ARRIVENT BIOPHARMA INC.
General Catalyst Group Management, LLC opened new stock positions in EIKON THERAPEUTICS INC, COUPANG INC (CPNG) and AMAZON COM INC (AMZN).
The top stock holdings of General Catalyst Group Management, LLC are IOT, , . The fund has invested 34.5% of it's portfolio in SAMSARA INC and 18.8% of portfolio in ARRIVENT BIOPHARMA INC.
General Catalyst Group Management, LLC opened new stock positions in EIKON THERAPEUTICS INC, COUPANG INC (CPNG) and AMAZON COM INC (AMZN).
General Catalyst Group Management, LLC Equity Portfolio Value
Last Reported on: 15 May, 2026
General Catalyst Group Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that General Catalyst Group Management, LLC made a return of -19.28% in the last quarter. In trailing 12 months, it's portfolio return was -36.49%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| eikon therapeutics inc | 3,229,360 |
| ethos technologies inc | 828,579 |
| coupang inc | 692,462 |
| amazon com inc | 537,753 |
| meta platforms inc | 376,462 |
New stocks bought by General Catalyst Group Management, LLC
Additions
Reductions
Sold off
Sector Distribution
General Catalyst Group Management, LLC has about 53.7% of it's holdings in Others sector.
- Others
- Technology
| Sector | % |
|---|---|
| Others | 53.7 |
| Technology | 45.4 |
Market Cap. Distribution
General Catalyst Group Management, LLC has about 34.9% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- LARGE-CAP
- MID-CAP
| Category | % |
|---|---|
| UNALLOCATED | 53.7 |
| LARGE-CAP | 34.9 |
| MID-CAP | 10.9 |
Stocks belong to which Index?
About 0% of the stocks held by General Catalyst Group Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
| Index | % |
|---|---|
| Others | 99.5 |
General Catalyst Group Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of General Catalyst Group Management, LLC
General Catalyst Group Management, LLC has 12 stocks in it's portfolio. GTLB proved to be the most loss making stock for the portfolio. was the most profitable stock for General Catalyst Group Management, LLC last quarter.
Last Reported on: 15 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AMZN | amazon com inc | 0.29 | 2,582 | 537,753 | new | |||
| CPNG | coupang inc | 0.38 | 36,677 | 692,462 | new | |||
| GTLB | gitlab inc | 10.86 | 921,405 | 19,939,200 | unchanged | 0.00 | ||
| IOT | samsara inc | 34.53 | 2,000,000 | 63,380,000 | unchanged | 0.00 | ||
| META | meta platforms inc | 0.20 | 658 | 376,462 | new | |||
| arrivent biopharma inc | 18.79 | 1,494,790 | 34,484,700 | unchanged | 0.00 | |||
| maze therapeutics inc | 16.84 | 1,035,910 | 30,921,900 | unchanged | 0.00 | |||
| maplebear inc | 14.50 | 710,711 | 26,623,200 | unchanged | 0.00 | |||
| eikon therapeutics inc | 1.76 | 305,233 | 3,229,360 | new | ||||
| fractyl health inc | 1.22 | 4,884,190 | 2,235,980 | unchanged | 0.00 | |||
| ethos technologies inc | 0.45 | 74,179 | 828,579 | new | ||||
| figma inc | 0.17 | 14,845 | 313,823 | unchanged | 0.00 | |||